透析に依存しない腎不全患者の冠動脈バイパス移植
1Division of Cardiovascular Surgery, Sunnybrook Health Science Centre and The Toronto Hospital, Ontario, Canada.
Circulation
|December 31, 1997
まとめ
軽度の腎不全で冠動脈バイパス移植 (CABG) 手術を受ける患者は,より高いリスクに直面します. これには,血液輸血の必要性が増加し,低出力症候群,および透析に依存することなくとも,より長い入院期間が含まれます.
科学分野:
- 心臓病学 心臓病学
- ネフロロジーはネフロロジーを用います.
- 外科手術の結果について
背景:
- 術前腎不全は,冠動脈バイパス移植 (CABG) 手術に関連する罹病率と死亡率のリスクを大幅に高めます.
- 軽度の非透析依存性腎不全の患者に対するCABGの影響は,大部分が特徴づけられていない.
研究 の 目的:
- この状態のない対照群と比較して,軽度の手術前の腎不全を有する患者の単離CABGのアウトカムを調査する.
主な方法:
- 術前腎不全 (血清クレアチニン>150マイクロモル/L) 患者38人のコホートは,CABG患者2978人 (1990年-1996年) から同定された.
- これらの患者は,6つの予後変数に基づいて152人の対照患者とマッチングされました.
- 術前透析を必要とする患者は分析から除外された.
主要な成果:
- 腎不全グループでは,高齢化,糖尿病,高血圧,外周血管疾患,左心室機能不全の罹患率が高かった.
- 腎不全の患者は,手術前後の輸血 (P<.001) と手術後の透析 (P<.01) を必要とする可能性が高くなりました.
- より長い換気時間,集中治療室 (ICU) の滞在,手術後の入院は,腎不全のグループで観察されました. 軽度の腎不全は,手術後の低出力症候群 (OR=3.6) を独立して予測した.
結論:
- 透析状態に関係なく,軽度の腎不全は,CABG中にリスクの増加と関連しています.
- これらのリスクには,輸血の可能性が高まり,低出力症候群の発生,ICUの延長,手術後の入院などが含まれる.
関連する概念動画
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...


